Preclinical CRO Market

Future Market Insights

Key Insight

The preclinical CRO market is projected to grow from USD 6.7 billion in 2025 to USD 12.2 billion by 2035, at a CAGR of 6.2%. Toxicology Testing will dominate with a 22.5% market share, while patient derived organoid (PDO) model will lead the model type outlook segment with a 59.0% share.

September 22, 2025

Anurag Sharma

250 Pages

Cite this Report

Preclinical CRO Market

https://www.futuremarketinsights.com/reports/preclinical-cro-market

License

Buy Now

Summary ToC Companies

Key Players

Charles River Laboratories International Inc
Crown Bioscience Inc
Eurofins Scientific
ICON plc
Intertek Group plc
Intertek Group Plc (IGP)
LabCorp
Medpace Holdings
SGA SA
WuXi AppTec

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Preclinical CRO Market

Key Players

Similar Industry Reports